FREISING, Germany–(BUSINESS WIRE)–PreciPoint Group GmbH has successfully closed its Series A financing round of EUR 10 million. Existing investors around bm-t beteiligungsmanagement th?ringen gmbh (bmt.
About PreciPoint:
PreciPoint specializes in the development, production and marketing of digitization solutions and photonics systems. Already available are the M8, O8 as well as FRITZ. These are fully motorized transmitted light microscopes, which produce high-resolution images and can be handled remotely. Additionally, the company offers software applications to visualize process and analyze, as well as the virtual microscopy platform PreciCloud to store and share the images. Based in Freising, Germany, PreciPoint is an ISO 13485 certified medical device company and one of the top startups in Germany. The company has won various awards, including a 3rd place as Top100 Innovator 2022 and Top Startup Employer in the healthcare sector.
FREISING, Germany–(BUSINESS WIRE)– #familyoffice–Successful completion of Series A: EUR 10 million investment for german medtech startup PreciPoint